Global Synthetic Biology Market 2024-2028
Technavio has been monitoring the synthetic biology market and is forecast to grow by USD 55600.6 mn during 2023-2028, accelerating at a CAGR of 34.1% during the forecast period. Our report on the synthetic biology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing applications leading to growing adoption of synthetic biology, growing investments in synthetic biology processes and techniques, and increasing demand for synthetic genes and synthetic cells.
Technavio's synthetic biology market is segmented as below:
By Application
- Healthcare
- Industrial
- Food and agriculture
- Others
By Product
- Oligonucleotides
- Enzymes
- Cloning technology kits
- Xeno-nucleic acids
- Chassis organism
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the evolving regulatory framework around synthetic biology as one of the prime reasons driving the synthetic biology market growth during the next few years. Also, industry moving toward cell-free environments and increasing strategic collaborations and acquisitions will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the synthetic biology market covers the following areas:
- Synthetic biology market sizing
- Synthetic biology market forecast
- Synthetic biology market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading synthetic biology market vendors that include Agilent Technologies Inc., Algenol, Amyris Inc., CD Biosynsis, Codexis Inc, Creative Biogene, Danaher Corp., Eurofins Scientific SE, Genomatica Inc., GenScript Biotech Corp., Ginkgo Bioworks Holdings Inc., Illumina Inc., Merck KGaA, New England Biolabs Inc., Novozymes AS, Precigen Inc., Sanofi SA, Synthego Corp., Thermo Fisher Scientific Inc., and Twist Bioscience Corp.. Also, the synthetic biology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.